EZH2 Mutations and Impact on Clinical Outcome Analyzed in 1604 Patients with Acute Myeloid Leukemia

Stasik S, Middeke JM, Kraemer M, Rollig C, Kramer A, Scholl S, Hochhaus A, Crysandt M, Bruemmendorf TH, Naumann R, Steffen B, Kunzmann V, Einsele H, Schaich M, Burchert A, Neubauer A, Schaefer-Eckart K, Schliemann C, Krause S, Herbst R, Haenel M, Frickhofen N, Noppeney R, Kaiser U, Baldus CD, Kaufmann M, Racil Z, Platzbecker U, Berdel WE, Mayer J, Serve H, Mueller-Tidow C, Ehninger G, Bornhaeuser M, Schetelig J, Thiede C (2018)


Publication Type: Conference contribution

Publication year: 2018

Journal

Publisher: AMER SOC HEMATOLOGY

City/Town: WASHINGTON

Conference Proceedings Title: BLOOD

Event location: San Diego, CA US

DOI: 10.1182/blood-2018-99-114421

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Stasik, S., Middeke, J.M., Kraemer, M., Rollig, C., Kramer, A., Scholl, S.,... Thiede, C. (2018). EZH2 Mutations and Impact on Clinical Outcome Analyzed in 1604 Patients with Acute Myeloid Leukemia. In BLOOD. San Diego, CA, US: WASHINGTON: AMER SOC HEMATOLOGY.

MLA:

Stasik, Sebastian, et al. "EZH2 Mutations and Impact on Clinical Outcome Analyzed in 1604 Patients with Acute Myeloid Leukemia." Proceedings of the 60th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA WASHINGTON: AMER SOC HEMATOLOGY, 2018.

BibTeX: Download